Study: Women Outlive Men During Lung Cancer Trials

Article here. Excerpt:

'CHICAGO, Nov. 18 -- Men involved in clinical studies of inoperable non-small-cell lung cancer appear to be at a 23% greater risk of mortality during a trial than comparable women, researchers said here.

Being a woman is a clear advantage, Corey Langer, M.D., director of thoracic oncology at the University of Pennsylvania, said at the 2008 Chicago Multidisciplinary Symposium on Thoracic Cancer.

"Across the board, independent of race or partnering status, men did worse than women," said Dr. Langer. "This is an observation that has been repeatedly observed in multiple epithelial malignancies, not just lung cancer."